Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 19 results:
Συντάκτης Τίτλος Τύπος [ Έτος] Φίλτρα: Συντάκτης is Garyfallos, Alexandros [Clear All Filters]
(2023).
Capturing the enthesitis related arthritis contemporary profile of Caucasian patients in the era of biologics..
Rheumatol Int. 40(6), 941-949.
(2020). Comparison of ambulatory central hemodynamics and arterial stiffness in patients with diabetic and non-diabetic CKD..
J Clin Hypertens (Greenwich).
(2020).
(2020).
(2020).
(2019).
The genetics and molecular pathogenesis of systemic lupus erythematosus (SLE) in populations of different ancestry..
Gene. 668, 59-72.
(2018). Novel insights into the role of inflammasomes in autoimmune and metabolic rheumatic diseases..
Rheumatol Int. 38(8), 1345-1354.
(2018). Anticholinergic syndrome induced by toxic plants..
World J Emerg Med. 8(4), 297-301.
(2017). A critical view on cardiovascular risk in systemic sclerosis..
Rheumatol Int. 37(1), 85-95.
(2017). Longterm Beneficial Effect of Canakinumab in Colchicine-resistant Familial Mediterranean Fever..
J Rheumatol. 44(1), 102-109.
(2017). Predictors and long-term outcome in Greek adults with juvenile idiopathic arthritis: a 17-year continuous follow-up study..
Rheumatology (Oxford). 56(11), 1928-1938.
(2017). Τhe genetics of juvenile idiopathic arthritis: Searching for new susceptibility loci..
Mol Med Rep. 16(6), 8793-8798.
(2017). Phenotyping Exercise Limitation in Systemic Sclerosis: The Use of Cardiopulmonary Exercise Testing..
Respiration. 91(2), 115-23.
(2016). Infliximab as a treatment option for patients with rheumatoid arthritis and primary biliary cirrhosis..
Rheumatol Int. 35(11), 1913-6.
(2015). Molecular and cellular pathways as treatment targets for biologic therapies in systemic sclerosis..
Curr Med Chem. 22(16), 1943-55.
(2015). Micro- and macrovascular treatment targets in scleroderma heart disease..
Curr Pharm Des. 20(4), 536-44.
(2014). B-type natriuretic peptide in rheumatic diseases: a cardiac biomarker or a sophisticated acute phase reactant?.
Autoimmun Rev. 11(12), 837-43.
(2012).
(2010).